Losartan, yet another blood pressure drug, recalled by the FDA
A third blood pressure medicine has been recalled by the U.S. Food and Drug Administration. Losartan was recalled over concerns that “the contaminated drug might cause cancer.” The latest recall follows that of irbesartan and valsartan earlier in the year.
Losartan potassium hydrochlorothiazide pills of the 100 milligram/25 milligram variety, produced by Sandoz Inc., have been recalled due to a possible contamination of N-nitrosodiethylamine (NDEA). According to the agency for Research on Cancer, NDEA is “a probable human carniogen”. The medication was distributed after October 8th, and has a lot number of JB8912. If you take this medication, you should seek out your doctor before deciding to cease its use.
For USA Today’s full report, click here: https://bit.ly/2RX59sb